TY  - JOUR
AU  - Groenendijk, Alissa
AU  - van Tinteren, Harm
AU  - Jiang, Yilin
AU  - de Krijger, Ronald R
AU  - Vujanic, Gordan M
AU  - Godzinski, Jan
AU  - Rübe, Christian
AU  - Schenk, Jens-Peter
AU  - Morosi, Carlo
AU  - Pritchard-Jones, Kathy
AU  - Al-Saadi, Reem
AU  - Vaidya, Sucheta J
AU  - Verschuur, Arnauld C
AU  - Ramírez-Villar, Gema L
AU  - Graf, Norbert
AU  - de Camargo, Beatriz
AU  - Drost, Jarno
AU  - Perotti, Daniela
AU  - van den Heuvel-Eibrink, Marry M
AU  - Brok, Jesper
AU  - Spreafico, Filippo
AU  - Mavinkurve-Groothuis, Annelies M C
PY  - 2022
DO  - 10.1016/j.ejca.2021.12.014
UR  - http://hdl.handle.net/10668/22171
T2  - European journal of cancer (Oxford, England : 1990)
AB  - Society of International Pediatric Oncology - Renal Tumor Study Group (SIOP-RTSG) treatment recommendations for relapsed Wilms tumour (WT) are stratified by the intensity of first-line treatment. To explore the evidence for the treatment of patients...
LA  - en
KW  - Recurrence
KW  - SIOP protocol
KW  - Treatment outcome
KW  - Wilms tumour
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carboplatin
KW  - Child
KW  - Dactinomycin
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Ifosfamide
KW  - Kidney Neoplasms
KW  - Male
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm Staging
KW  - Retrospective Studies
KW  - Vincristine
KW  - Wilms Tumor
TI  - Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
TY  - research article
VL  - 163
ER  -